Skip to main content

This job has expired

Global Maternal Immunization Medical Affairs Lead (U.S) - non-MD

Employer
Pfizer
Location
Remote, Remote, United States; Collegeville, Pennsylvania, United States;
Salary
Competitive
Closing date
Dec 4, 2022

View more

Discipline
Health Sciences, Medicine
Position Type
Full Time
Organization Type
Pharma
ROLE SUMMARY

Maternal immunization, the administration of a vaccines during pregnancy, is a well-recognized, public health strategy which aims to protect pregnant people and/or their infants against serious infectious diseases. Pfizer MDSCA has recently established a Maternal Immunization Platform; an innovative approach to integrating the medical affairs function across several vaccine programs including RSV, GBS and Covid19.

The Global Maternal Lead will be accountable for specific aspects of the Global Maternal Immunization Medical Plan as they pertain to the but also in support of priority IDM and EM countries. This will include expert contribution to the development and execution of an integrated medical strategy for each of the maternal programs appropriate to its current status within the clinical development. The development of a medical position on the risk-benefit of each of the assets will be critical given the importance of the larger safety narrative of maternal immunizations in general; the communication of that position both internally and externally will be equally critical. In parallel, the Lead will help to further develop the disease narrative for each program, the RSV scientific platform, and any appropriate medical materials to be used in establishing general maternal immunization expertise for both internal and external use globally. A large focus for the Maternal Lead will be to provide strategic input into but also global evidence generation and dissemination plans as they prepare for program specific milestones.

The Maternal Lead will be responsible for guiding specific business decisions and ensuring strategic alignment between the Vaccines BU and RU for maternal vaccines for topics relevant to the but also in support of priority IDM and EM countries. She/he/they will do this by providing an expert understanding of immunology, vaccine clinical research and development, regulatory pathways, and vaccine policy decision processes and decisions. In addition, where relevant, they will ensure strategic alignment and coordination with the medical leads of other age based indications (pediatric/older adult, etc) which fall under the same infectious disease program. The Maternal Lead will contribute to the productivity of Pfizer vaccines by responsibly exploring novel initiatives and providing expertise during participation in all aspects of governance committees, and teams to which she/he/they are assigned. The Maternal Lead will help shape the strategic and scientific direction of all observational clinical/epidemiological maternal vaccine studies for MDSCA ensuring highest standards of quality and compliance and management of all prospective CT25, CT45, CT02, and CT44 studies. The Maternal Lead will be responsible to review all the safety aspects of maternal vaccines in promotional materials, publications, and interactions with KOLs and vaccine Technical Committees. She/he/they will make decisions based on clinical experience within the healthcare system, hospital setting, and/or outpatient care facilities.

Finally, the candidate should be able to demonstrate a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop, and coach others, oversee, and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

ROLE RESPONSIBILITIES

As the Global Maternal Immunization Medical Affairs Lead, the incumbent will be responsible for leading select medical affairs activities for maternal vaccines globally with a primary focus on the US priority IDM and EM countries. This will entail the following:
  • Assist in developing and launching the three year Pfizer maternal immunization strategic plan in partnership with key functional areas
  • Initiate maternal immunization campaign to help prepare the ground for Pfizer maternal immunization programs in development or already in use
  • Serves as MDSCA project champion, effectively negotiating with & influencing key internal & external stakeholders including the Gates Foundation, WHO, and disease specific consortiums such as ReSViNET, ISSAD and INMIS
  • Develop the maternal immunization safety narrative with particular focus on inclusion of data from US countries in order to further support global efforts in addressing vaccine hesitancy
  • MDSCA focal point for all safety reviews in promotional materials and safety presentations to KOLs and VTCs with respect to maternal vaccines.
  • Partners with safety and safety epidemiology to assess progress of pharmacovigilance plans and respond to queries from regulatory authorities and other health authorities in relation to maternal vaccines.
  • Accountable for MDSCA global strategy to evaluate potential recommendations for each of the maternal vaccine programs worldwide with particular focus the US but also in support of priority IDM and EM countries
  • Work closely with Maternal Immunization Scientific Affairs Lead to tailor evidence generation plans in support of optimal recommendation in the US but also in support of priority IDM and EM countries
  • MDSCA focal point for the US Vaccine Technical Committee (ACIP) with respect to maternal vaccine programs
  • Will support successful policy recommendations and launch for maternal vaccines in the US and support priority IDM and EM countries where needed
  • Support pre-asset, asset and MSC teams with aggregated global data on studies via Pfizer-sponsored and collaborative research in order to support of individual program strategies
  • Partner with the global medical grants / IIR department for global view of maternal vaccine studies and grant requests and facilitating implementation clinically where needed.
  • Accountable for the Medical and Lifecycle Plans and deliverables for the RSV and GBS maternal vaccine programs appropriate to their stage in clinical development
  • Serves as the leading advocate for the Vaccines Medical organization and champions MDSCA resources, needs, and priorities for the appropriate use of maternal vaccines.
  • Partners with Commercial Development (CD) to ensure MDSCA-CD alignment on key strategies, deliverables, and communication for maternal vaccines


BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
  • PhD with additional research training in one or more of the following areas: infectious disease, public health, epidemiology, vaccinology, clinical development, or closely-related field
  • At least 10 years of experience in US/Global medical affairs including vaccine-related clinical programs and medical/scientific activities
  • Expertise in vaccines and immunization programs with an established international KOL network; maternal immunization program experience highly preferred
  • Ability to discuss scientific aspects of vaccine development, including vaccine related commercial and regulatory issues.
  • Able to review, evaluate, interpret, and present complex vaccine and epidemiological data.
  • Excellent verbal and written communication skills including scientific writing skills
  • Strong inter-personal skills.
  • Demonstrated ability to create and articulate global strategies while also understanding how to tailor those global strategies for specific country needs


PREFERRED QUALIFICATIONS
  • Significant cross-functional leadership/management experience
  • Able to set priorities and manage cross-functional teams and complex projects to deliver milestones according to set budgets.
  • Proven ability to influence and succeed through others and to form excellent relationships with key cross-functional stakeholders.
  • Demonstrated strong work ethic, and proven track record of delivering high quality within timelines.
  • Successfully interacted with regulatory and government agencies regarding vaccines indication and/or labeling issues.
  • Knowledgeable of the commercial and environmental issues that drive development vaccine projects.
  • Understand the emerging safety and efficacy profile of vaccine candidates including providing a perspective with comparator vaccines.


Other Job Details:

Last Date to Apply for Job: December 2nd, 2022

Additional Location Information: New York, NY; Collegeville, PA; US - Remote

#LI-PFE

For roles based in New York City: The annual base salary for this position ranges from $178,700.00 to $297,700.00. In addition, this position offers an annual bonus with a target of 22.5% of the base salary and eligibility to participate in our share based long term incentive program. Benefits offered include a retirement savings plan, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans.

Relocation assistance may be available based on business needs and/or eligibility.

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Medical

#LI-PFE

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert